Surgical management of intractable interstitial cystitis

G. Zhang*, D. Kappor, A. Sidi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Interstitial cystitis represents a diagnostic and therapeutic challenge. Most patients can be managed conservatively, but a small number of patients do not respond to conservative therapy and for them surgical treatment is indicated. This article reviews the historical and currently used surgical modalities. Enterocystoplasty is the surgical treatment of choice for intractable interstitial cystitis. The results of enterocystoplasty are satisfactory in approximately 80% of patients. However, no histological findings, such as mast cell density or degree of inflammation, can be used as a preoperative predictor of treatment results. The best results of cystoplasty seem to be achieved in patients who have a small bladder capacity, determined preoperatively under anesthesia. Approximately 10%-20% of patients may not be able to void spontaneously after surgery and require self-catheterization. Because of the unpredictable results, cystoplasty must be recommended with caution for certain patients. There is no evidence to indicate that a supratrigonal cystectomy and substitution cystoplasty offer a therapeutic advantage over augmentation cystoplasty alone. The choice of bowel segment does not affect the final outcome provided that it is tubularized and made spherical in configuration.

Original languageEnglish
Pages (from-to)155-162
Number of pages8
JournalInternational Urogynecology Journal
Issue number2
StatePublished - Jun 1992
Externally publishedYes


  • Augmentation enterocystoplasty
  • Intractable interstitial cystitis


Dive into the research topics of 'Surgical management of intractable interstitial cystitis'. Together they form a unique fingerprint.

Cite this